SPONSORED NEWS ARCHIVE
Article from: U.S. News & World Report
Article date: November 03, 2008
Author: Pethokoukis, James
Byline: James Pethokoukis
An Obama presidency is supposed to be bad news for drug stocks. Then why are Merck and Pfizer outperforming the S&P 500 for the past two weeks? And UnitedHealth Group, supposedly an "Obama stock," has been getting battered. Both stocks, by the way, would be considered defensive stocks, so there must be more to it than that. Maybe Mr. Market knows something the pollsters don't.
Read the rest of this article with a Free Trial at HighBeam Research.